(Q40921205)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9001839%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

review article

1 reference

title

The economics of benign prostatic hyperplasia treatment: a literature review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9001839%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

main subject

prostatic hypertrophy

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9001839%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

J L Bootman

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9001839%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 November 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9001839%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

published in

Clinical Therapeutics

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9001839%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9001839%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9001839%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

1227-1241

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9001839%20AND%20SRC:MED&resulttype=core&format=json

Prostatism and the burden of benign prostatic hyperplasia on elderly men.

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980078-6

7 January 2021

The prostate: an increasing medical problem

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980078-6

7 January 2021

Evaluation and results of treatments for prostatism.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980078-6

7 January 2021

The cost-effectiveness of terazosin and placebo in the treatment of moderate to severe benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980078-6

7 January 2021

Comparison of the cost-effectiveness of various therapies for common prostatic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980078-6

7 January 2021

Urologists on a tightrope: coping with a changing economy.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980078-6

7 January 2021

Discounting surgical benefits. Enucleation versus resection of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980078-6

7 January 2021

Economic modeling to assess the costs of treatment with finasteride, terazosin, and transurethral resection of the prostate for men with moderate to severe symptoms of benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980078-6

7 January 2021

Economic burden of treated benign prostatic hyperplasia in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980078-6

7 January 2021

Patient recruitment to and cost of a prospective trial of medical treatment for benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980078-6

7 January 2021

The costs of prostatectomy for benign prostatic hyperplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980078-6

7 January 2021

Annual costs of benign prostatic hyperplasia in New Zealand.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980078-6

7 January 2021

An economic evaluation of finasteride for treatment of benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980078-6

7 January 2021

Cost-of-illness studies: a major headache?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980078-6

7 January 2021

Antidepressant pharmacotherapy: economic evaluation of fluoxetine, paroxetine and sertraline in a health maintenance organization

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980078-6

7 January 2021

10.1016/S0149-2918(96)80078-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9001839%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference